BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11814312)

  • 21. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.
    Maedler K; Sergeev P; Ehses JA; Mathe Z; Bosco D; Berney T; Dayer JM; Reinecke M; Halban PA; Donath MY
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8138-43. PubMed ID: 15141093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts.
    Maret M; Chicheportiche R; Dayer JM; Gabay C
    Cytokine; 2004 Mar; 25(5):193-203. PubMed ID: 15036245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
    Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
    J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR2 expression in relation to IL-6 and IL-1beta and their natural regulators production by PMN and PBMC in patients with Lyme disease.
    Jablonska E; Marcinczyk M
    Mediators Inflamm; 2006; 2006(1):32071. PubMed ID: 16864901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human milk anti-inflammatory component contents during acute mastitis.
    Buescher ES; Hair PS
    Cell Immunol; 2001 Jun; 210(2):87-95. PubMed ID: 11520075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.
    Tominaga K; Habu M; Sukedai M; Hirota Y; Takahashi T; Fukuda J
    Arch Oral Biol; 2004 Jun; 49(6):493-9. PubMed ID: 15099807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis].
    Pietruczuk A; Swierzbińska R; Pietruczuk M; Hermanowska-Szpakowicz T
    Pol Merkur Lekarski; 2004 Nov; 17(101):446-50. PubMed ID: 15754629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L; Remick DG
    Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
    Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
    Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis.
    Pietruczuk A; Swierzbińska R; Pancewicz S; Pietruczuk M; Hermanowska-Szpakowicz T
    Infection; 2006 Jun; 34(3):158-62. PubMed ID: 16804660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer.
    Jablonska E; Puzewska W; Grabowska Z; Jablonski J; Talarek L
    Cytokine; 2005 May; 30(3):93-9. PubMed ID: 15826815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.
    Malyak M; Smith MF; Abel AA; Arend WP
    J Clin Immunol; 1994 Jan; 14(1):20-30. PubMed ID: 8132734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.
    Gouze JN; Gouze E; Palmer GD; Liew VS; Pascher A; Betz OB; Thornhill TS; Evans CH; Grodzinsky AJ; Ghivizzani SC
    Arthritis Res Ther; 2003; 5(5):R301-9. PubMed ID: 12932294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
    Jablonska E
    Mediators Inflamm; 2002 Oct; 11(5):325-8. PubMed ID: 12467526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae.
    Holcberg G; Amash A; Sapir O; Sheiner E; Levy S; Myatt L; Huleihel M
    Placenta; 2008 Jul; 29(7):593-601. PubMed ID: 18471873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia.
    Calkins CM; Bensard DD; Shames BD; Pulido EJ; Abraham E; Fernandez N; Meng X; Dinarello CA; McIntyre RC
    J Endotoxin Res; 2002; 8(1):59-67. PubMed ID: 11981446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over expression of interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist in testicular tissues from sexually immature mice as compared to adult mice.
    Huleihel M; Lunenfeld E; Blindman A; Prinsloo I; Potashnik G
    Eur Cytokine Netw; 2003; 14(1):27-33. PubMed ID: 12799211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.
    Schröder AK; von der Ohe M; Kolling U; Altstaedt J; Uciechowski P; Fleischer D; Dalhoff K; Ju X; Zenke M; Heussen N; Rink L
    Immunology; 2006 Nov; 119(3):317-27. PubMed ID: 17067311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.